Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease

被引:158
|
作者
Tattersfield, AS
Croon, RJ
Liu, YW
Kells, AP
Faull, RLM
Connor, B
机构
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
关键词
neurogenesis; progenitor cells; striatum; subventricular zone; basal ganglia; neurodegeneration;
D O I
10.1016/j.neuroscience.2004.04.061
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The presence of ongoing neurogenesis in the adult mammalian brain raises the exciting possibility that endogenous progenitor cells may be able to generate new neurons to replace cells lost through brain injury or neuro-degenerative disease. We have recently demonstrated increased cell proliferation and the generation of new neurons in the Huntington's disease human brain. In order to better understand the potential role of endogenous neuronal replacement in neurodegenerative disorders and extend our initial observations in the human Huntington's disease brain, we examined the effect of striatal cell loss on neurogenesis in the subventricular zone (SVZ) of the adult rodent forebrain using the quinolinic acid (QA) lesion rat model of Huntington's disease. Cell proliferation and neurogenesis were assessed with bromodeoxyuricline (BrdU) labeling and immunocytochemistry for cell type-specific markers. BrdU labeling demonstrated increased cell proliferation in the SVZ ipsilateral to the QA-lesioned striatum, resulting in expansion of the SVZ in the lesioned hemisphere. Quantification revealed that QA lesion-induced striatal cell loss produced a significant increase in the area of BrdU-immunoreactivity in the SVZ ipsilateral to the lesioned hemisphere between 1 and 14 days post-lesion compared with sham-lesioned animals, with the greatest increase observed at 7 days post-lesion. These changes were associated with an increase in cells in the anterior SVZ ipsilateral to the lesioned striatum expressing the antigenic marker for SVZ neuroblasts, doublecortin (Dcx). Importantly, we observed Dcx-positive cells extending from the SVZ into the QA-lesioned striatum where a subpopulation of newly generated cells expressed markers for immature and mature neurons. This study demonstrates that loss of GABAergic medium spiny projection neurons following QA striatal lesioning of the adult rat brain increases SVZ neurogenesis, leading to the putative migration of neuroblasts to damaged areas of the striatum and the formation of new neurons. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:319 / 332
页数:14
相关论文
共 50 条
  • [1] AAV-BDNF augments neurogenesis in both the normal adult rat brain and the quinolinic acid lesion model of Huntington's disease
    Connor, B
    Henry, RA
    Faull, RLM
    Hughes, SM
    EXPERIMENTAL NEUROLOGY, 2006, 198 (02) : 565 - 565
  • [2] AAV-BDNF Augments Neurogenesis in Both the Normal Adult Rat Brain and the Quinolinic Acid Lesion Model of Huntington's Disease
    Henry, Rebecca A.
    Hughes, Stephanie M.
    Faull, Richard L. M.
    Connor, Bronwen J.
    MOLECULAR THERAPY, 2006, 13 : S174 - S174
  • [3] Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease
    Joel, D
    Ayalon, L
    Tarrasch, R
    Veenman, L
    Feldon, J
    Weiner, I
    BRAIN RESEARCH, 1998, 787 (01) : 143 - 148
  • [4] Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease
    Jiang, Wei
    Buechele, Fabian
    Papazoglou, Anna
    Doebroessy, Mate
    Nikkhah, Guido
    JOURNAL OF NEUROSCIENCE METHODS, 2009, 179 (02) : 219 - 223
  • [5] Electrolytic lesion of Globus pallidus ameliorates the behavioral effects of quinolinic cid lesion of the striatum: A potential novel treatment in a rat model of Huntington's disease
    Ayalon, L
    Joel, D
    Tarrasch, R
    Feldon, J
    Weiner, I
    NEUROSCIENCE LETTERS, 1997, : S5 - S5
  • [6] Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease
    Joel, D
    Ayalon, L
    Tarrasch, R
    Weiner, I
    MOVEMENT DISORDERS, 2003, 18 (12) : 1499 - 1507
  • [7] Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease
    Ryu, JK
    Kim, SU
    McLarnon, JG
    EXPERIMENTAL NEUROLOGY, 2003, 183 (02) : 700 - 704
  • [8] Behaviour characterization of a model of Huntington's disease in rats, induced by quinolinic acid
    Francis, L
    Cruz, R
    Antúnez, I
    Rosillo, JC
    REVISTA DE NEUROLOGIA, 2000, 30 (11) : 1016 - 1021
  • [9] The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease
    Alexi, T
    Hughes, PE
    van Roon-Mom, WMC
    Faull, RLM
    Williams, CE
    Clark, RG
    Gluckman, PD
    EXPERIMENTAL NEUROLOGY, 1999, 159 (01) : 84 - 97
  • [10] Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
    Giampa, Carmela
    Patassini, Stefano
    Borreca, Antonella
    Laurenti, Daunia
    Marullo, Fabrizia
    Bernardi, Giorgio
    Menniti, Frank S.
    Fusco, Francesca R.
    NEUROBIOLOGY OF DISEASE, 2009, 34 (03) : 450 - 456